Related Experiment Video
Updated: Jun 17, 2026
06:44
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Published on: April 13, 2018
Thrombosis in systemic lupus erythematosus.
Anita Palatinus1, Murray Adams
1School of Human Life Sciences, University of Tasmania, Tasmania, Australia.
Seminars in Thrombosis and Hemostasis
|December 17, 2009
Summary
Systemic lupus erythematosus (SLE) is a complex inflammatory disease affecting multiple organs, often diagnosed late. Antiphospholipid antibodies contribute to thrombosis risk in SLE patients.
Area of Science:
- Rheumatology
- Immunology
- Pathophysiology
Background:
- Systemic lupus erythematosus (SLE) is a severe, multi-organ inflammatory condition predominantly affecting women.
- Diagnosis of SLE is challenging due to diverse clinical presentations and the absence of highly specific and sensitive diagnostic markers.
- The exact causes of SLE are unknown but likely involve a combination of environmental, genetic, and hormonal factors.
Purpose of the Study:
- To summarize the current understanding of Systemic Lupus Erythematosus (SLE) pathophysiology.
- To highlight the diagnostic challenges associated with SLE.
- To review the increased risk of thrombosis and atherosclerosis in SLE patients and the role of antiphospholipid antibodies.
Main Methods:
- Literature review of existing studies on SLE.
- Analysis of factors contributing to SLE development and progression.
- Examination of the relationship between SLE, antiphospholipid antibodies, and thrombotic events.
Main Results:
- SLE is characterized by heterogeneous clinical manifestations, complicating diagnosis.
- Patients with SLE face a significantly higher risk of premature thrombosis and atherosclerosis.
- Antiphospholipid antibodies are implicated in promoting thrombosis through interactions with hemostatic proteins and platelets.
Conclusions:
- Despite advances, earlier diagnosis of SLE remains a significant challenge.
- Predicting and preventing thrombotic events in SLE patients requires further research and improved strategies.
- Understanding the role of antiphospholipid antibodies is crucial for managing thrombotic risks in SLE.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...